{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:00:42Z","timestamp":1789545642171,"version":"build-2803163510"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.16357","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T01:49:43Z","timestamp":1625881783000},"page":"e2116357","source":"Crossref","is-referenced-by-count":31,"title":["Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US"],"prefix":"10.1001","volume":"4","author":[{"given":"Kaustuv","family":"Bhattacharya","sequence":"first","affiliation":[{"name":"Center for Pharmaceutical Marketing and Management, University of Mississippi School of Pharmacy, University"},{"name":"Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bentley","sequence":"additional","affiliation":[{"name":"Center for Pharmaceutical Marketing and Management, University of Mississippi School of Pharmacy, University"},{"name":"Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujith","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Center for Pharmaceutical Marketing and Management, University of Mississippi School of Pharmacy, University"},{"name":"Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhee","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Hospitality Management, University of Mississippi, University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Benjamin F.","family":"Banahan","sequence":"additional","affiliation":[{"name":"Center for Pharmaceutical Marketing and Management, University of Mississippi School of Pharmacy, University"},{"name":"Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchit","family":"Shah","sequence":"additional","affiliation":[{"name":"Pharmerit International, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickhill","family":"Bhakta","sequence":"additional","affiliation":[{"name":"Department of Global Pediatric Medicine, St Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Center for Pharmaceutical Marketing and Management, University of Mississippi School of Pharmacy, University"},{"name":"Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"issue":"4","key":"zoi210489r1","first-page":"204","article-title":"Estimating the costs of therapy in patients with relapsed and\/or refractory multiple myeloma: a model framework.","volume":"8","author":"Roy","year":"2015","journal-title":"Am Health Drug Benefits"},{"issue":"9","key":"zoi210489r2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12032-017-1001-7","article-title":"Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.","volume":"34","author":"Chen","year":"2017","journal-title":"Med Oncol"},{"issue":"7","key":"zoi210489r4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.18553\/jmcp.2008.14.S7-A.19","article-title":"Economic and clinical impact of multiple myeloma to managed care.","volume":"14","author":"Cook","year":"2008","journal-title":"J Manag Care Pharm"},{"issue":"9","key":"zoi210489r5","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/leu.2016.380","article-title":"Trends in overall survival and costs of multiple myeloma, 2000-2014.","volume":"31","author":"Fonseca","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"zoi210489r6","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1177\/030089161309900434","article-title":"Cost of illness in patients with multiple myeloma in Italy: the CoMiM study.","volume":"99","author":"Petrucci","year":"2013","journal-title":"Tumori"},{"issue":"1","key":"zoi210489r7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1186\/s12885-016-2835-7","article-title":"Phase-specific and lifetime costs of cancer care in Ontario, Canada.","volume":"16","author":"de Oliveira","year":"2016","journal-title":"BMC Cancer"},{"issue":"12","key":"zoi210489r8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1097\/00005650-199912000-00008","article-title":"Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.","volume":"37","author":"Brown","year":"1999","journal-title":"Med Care"},{"issue":"8","key":"zoi210489r9","first-page":"IV-104","article-title":"Estimating health care costs related to cancer treatment from SEER-Medicare data.","volume":"40","author":"Brown","year":"2002","journal-title":"Med Care"},{"issue":"4","key":"zoi210489r10","doi-asserted-by":"publisher","first-page":"E151","DOI":"10.9778\/cmajo.20130041","article-title":"Trends in use and cost of initial cancer treatment in Ontario: a population-based descriptive study.","volume":"1","author":"de Oliveira","year":"2013","journal-title":"CMAJ Open"},{"issue":"3","key":"zoi210489r11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/bju.2010.105.issue-3","article-title":"Healthcare costs associated with prostate cancer: estimates from a population-based study.","volume":"105","author":"Krahn","year":"2010","journal-title":"BJU Int"},{"issue":"9","key":"zoi210489r12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/jnci\/djn103","article-title":"Cost of care for elderly cancer patients in the United States.","volume":"100","author":"Yabroff","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"zoi210489r13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy.","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"issue":"8","key":"zoi210489r14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi210489r15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/COC.0000000000000238","article-title":"Total lifetime and cancer-related costs for elderly patients diagnosed with anal cancer in the United States.","volume":"41","author":"Deshmukh","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"zoi210489r16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clml.2014.09.004","article-title":"Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.","volume":"15","author":"Go","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"zoi210489r17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.18553\/jmcp.2011.17.8.610","article-title":"Determinants of Medicare all-cause costs among elderly patients with renal cell carcinoma.","volume":"17","author":"Hollenbeak","year":"2011","journal-title":"J Manag Care Pharm"},{"key":"zoi210489r18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/CEOR.S31552","article-title":"Techniques for estimating health care costs with censored data: an overview for the health services researcher.","volume":"4","author":"Wijeysundera","year":"2012","journal-title":"Clinicoecon Outcomes Res"},{"issue":"6","key":"zoi210489r20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi210489r21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jgo.2012.12.005","article-title":"A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes.","volume":"4","author":"Davidoff","year":"2013","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"zoi210489r22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1472-6963-12-224","article-title":"Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis\u2014a population-based nationwide registry study of 127,000 incident adult cancer patients.","volume":"12","author":"Christensen","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"zoi210489r23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MLR.0b013e3182731277","article-title":"When does an episode of care for cancer begin?","volume":"51","author":"Hornbrook","year":"2013","journal-title":"Med Care"},{"issue":"1","key":"zoi210489r24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00005650-199101000-00004","article-title":"Estimating the treatment costs of breast and lung cancer.","volume":"29","author":"Baker","year":"1991","journal-title":"Med Care"},{"issue":"6","key":"zoi210489r25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jnci\/87.6.417","article-title":"Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care.","volume":"87","author":"Taplin","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"zoi210489r26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/13696998.2017.1391818","article-title":"Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma.","volume":"21","author":"Atkins","year":"2018","journal-title":"J Med Econ"},{"issue":"3","key":"zoi210489r27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"4","key":"zoi210489r28","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/hep.v58.4","article-title":"Health care costs associated with hepatocellular carcinoma: a population-based study.","volume":"58","author":"Thein","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"zoi210489r29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/biostatistics\/kxh020","article-title":"Estimating marginal and incremental effects on health outcomes using flexible link and variance function models.","volume":"6","author":"Basu","year":"2005","journal-title":"Biostatistics"},{"issue":"1-2","key":"zoi210489r30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10742-011-0072-8","article-title":"Estimating treatment effects on healthcare costs under exogeneity: is there a \u201cmagic bullet\u201d?","volume":"11","author":"Basu","year":"2011","journal-title":"Health Serv Outcomes Res Methodol"},{"issue":"7","key":"zoi210489r31","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1634\/theoncologist.2017-0481","article-title":"Costs of cancer care across the disease continuum.","volume":"23","author":"Kaye","year":"2018","journal-title":"Oncologist"},{"issue":"4","key":"zoi210489r32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.6004\/jnccn.2017.7065","article-title":"Medical care costs associated with cancer in integrated delivery systems.","volume":"16","author":"Banegas","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"15","key":"zoi210489r33","article-title":"Drivers of phase-based costs in patients with multiple myeloma.","volume":"36","author":"Aly","year":"2018","journal-title":"J Clin Oncol."},{"issue":"7","key":"zoi210489r34","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/MLR.0b013e3181a2d847","article-title":"Overview of methods to estimate the medical costs of cancer.","volume":"47","author":"Barlow","year":"2009","journal-title":"Med Care"},{"issue":"2","key":"zoi210489r35","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2008.08.034","article-title":"Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.","volume":"7","author":"Lang","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"zoi210489r36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/archdermatol.2009.389","article-title":"Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)\u2013Medicare data.","volume":"146","author":"Seidler","year":"2010","journal-title":"Arch Dermatol"},{"issue":"1","key":"zoi210489r37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3816\/CCC.2006.n.021","article-title":"Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer.","volume":"6","author":"Paramore","year":"2006","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"zoi210489r38","first-page":"III63","article-title":"Measuring costs: administrative claims data, clinical trials, and beyond.","volume":"40","author":"Etzioni","year":"2002","journal-title":"Med Care"},{"issue":"37","key":"zoi210489r39","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1200\/EDBK_174909","article-title":"The oncology care model: perspectives from the Centers for Medicare & Medicaid Services and participating oncology practices in academia and the community.","volume":"37","author":"Kline","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"10","key":"zoi210489r40","doi-asserted-by":"publisher","first-page":"e1078","DOI":"10.1200\/JOP.19.00569","article-title":"Multiple myeloma cost of care under the oncology care model: the influence of high-cost therapies.","volume":"16","author":"Theroux","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"zoi210489r41","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1016\/j.jval.2020.04.1489","article-title":"RE4 performance-based payment determination in the oncology care model: factors associated with exceeding target price in prostate cancer episodes.","volume":"23","author":"Waters","year":"2020","journal-title":"Value Health"},{"issue":"8","key":"zoi210489r42","first-page":"IV-3","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"zoi210489r3","unstructured":"American Cancer Society. Key statistics for multiple myeloma. 2018. Accessed January 5, 2019. https:\/\/www.cancer.org\/cancer\/multiple-myeloma\/about\/key-statistics.html"},{"key":"zoi210489r19","unstructured":"US Bureau of Labor Statistics. Consumer Price Index (CPI) databases: Accessed November 27, 2020. https:\/\/www.bls.gov\/cpi\/data.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2781731\/bhattacharya_2021_oi_210489_1624993485.89531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T01:49:57Z","timestamp":1625881797000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2781731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.16357","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}